Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?
Cancer cells normally develop the ability to rewire or reprogram themselves to become resistant to treatments that were previously effective. Despite progress in understanding drug resistance, knowledge gaps remain regarding the underlying biological causes of drug resistance and the design of cance...
Saved in:
Main Authors: | Vera Machado (Author), Mariana Morais (Author), Rui Medeiros (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration-Where Are We Now?
by: Mariana Ferreira, et al.
Published: (2024) -
Where are we now and where are we headed?
by: Ewan A. Langan
Published: (2023) -
Biomedical Applications of Hyaluronic Acid-Based Nanomaterials in Hyperthermic Cancer Therapy
by: Subin Kim, et al.
Published: (2019) -
Cannabinoids in Periodontology: Where Are We Now?
by: Yésica Carmona Rendón, et al.
Published: (2023) -
Osteochondral techniques: where are we now?
by: Giovanna Medina, et al.
Published: (2023)